Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
1087PDF: 28Supplementary: 316Appendix: 264 -
Lipoprotein(a): what clinicians need to know
322PDF: 676HTML: 23 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2486PDF: 658Conflict of interest: 320SUPPLEMENTARY MATERIAL: 256HTML: 62 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
778PDF: 194Supplementary: 151Appendix: 105HTML: 37 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
764PDF: 216Supplementary: 142Appendix: 111HTML: 33 -
Modulation of cardiac metabolism in heart failure
2350PDF: 1148HTML: 26 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2306PDF: 392Appendix B: 436Appendix A: 318HTML: 2 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
131PDF: 51Supplementary: 10HTML: 1 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
183PDF: 232Supplementary: 147HTML: 21 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1116pdf: 244Supplementary Material: 40HTML: 121 -
-
Evolving targets for heart failure: the journey so far
2036pdf: 327HTML: 4 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1928PDF: 519SUPPLEMENTARY MATERIAL: 301GRAPHICAL ABSTRACT: 265HTML: 27 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1115PDF: 261Supplementary: 159HTML: 89

